Literature DB >> 3174449

Chemical synthesis of DNA oligomers containing cytosine arabinoside.

G P Beardsley1, T Mikita, M M Klaus, A L Nussbaum.   

Abstract

The solid phase phospite triester synthesis of oligodeoxynucleotides containing cytosine arabinoside (araC) is described. A protected araC phosphoramadite was prepared for the introduction of araC residues at 5'termini and internucleotide positions in DNA oligomers. These oligomers were utilized to demonstrate the formation of correct 3'-5' linkages, to test for alkaline lability at the araC site, and to study the stability of duplexes containing araC-G base pairs. For the introduction of araC residues at 3' terminal positions, a protected derivative of araC was coupled to functionalized silica. This material was used to prepare a test oligomer which was characterized enzymatically.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3174449      PMCID: PMC338698          DOI: 10.1093/nar/16.19.9165

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  14 in total

1.  THE QUANTITATIVE MICRODETERMINATION OF TRIPHENYLMETHYL ETHERS AS APPLIED TO NUCLEOTIDE SYNTHESIS.

Authors:  A M DUFFIELD; A L NUSSBAUM
Journal:  Anal Biochem       Date:  1964-02       Impact factor: 3.365

Review 2.  The mechanism of action of inhibitors of DNA synthesis.

Authors:  N R Cozzarelli
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Nucleic acids. I. The synthesis of nucleotides and dinucleoside phosphates containing ara-cytidine.

Authors:  W J Wechter
Journal:  J Med Chem       Date:  1967-09       Impact factor: 7.446

4.  Arabinosylcytosine stability in aqueous solutions: pH profile and shelflife predictions.

Authors:  R E Notari; M L Chin; R Wittebort
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

5.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

Authors:  E Frei; J N Bickers; J S Hewlett; M Lane; W V Leary; R W Talley
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

6.  Structure, dynamics, and energetics of deoxyguanosine . thymidine wobble base pair formation in the self-complementary d(CGTGAATTCGCG) duplex in solution.

Authors:  D J Patel; S A Kozlowski; L A Marky; J A Rice; C Broka; J Dallas; K Itakura; K J Breslauer
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

7.  Comparison of arabinose and ribose nucleoside conformation in aqueous and dimethylsulfoxide solution. 2',5'-Hydrogen bonding in arabinonucleosides.

Authors:  J G Dalton; A L George; F E Hruska; T N McGaig; K K Ogilvie; J Pelling; D J Wood
Journal:  Biochim Biophys Acta       Date:  1977-10-04

8.  Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.

Authors:  P P Major; E M Egan; G P Beardsley; M D Minden; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Instability of (ara-C) DNA under alkaline conditions.

Authors:  P P Major; E M Egan; D Herrick; D W Kufe
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

10.  Treatment of acute leukemia in adults.

Authors:  B D Clarkson; M D Dowling; T S Gee; I B Cunningham; J H Burchenal
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

View more
  3 in total

1.  Synthesis and restriction enzyme analysis of oligodeoxyribonucleotides containing the anti-cancer drug 2',2'-difluoro-2'-deoxycytidine.

Authors:  F C Richardson; K K Richardson; J S Kroin; L W Hertel
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

2.  Cytarabine-induced destabilization of a model Okazaki fragment.

Authors:  W H Gmeiner; A Skradis; R T Pon; J Liu
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

3.  Preparation and hybridization properties of oligonucleotides containing 1-alpha-D-arabinofuranosylthymine.

Authors:  A D Adams; C R Petrie; R B Meyer
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.